Mark Rosenberg
Heidelberg University
28 Papers
84 Citations
Mark Rosenberg is an academic researcher from Heidelberg University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 14, co-authored 28 publications.
Chat about Author
Papers
Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction A First-in-Man Study
Norbert Frey,Axel Linke,Tim Süselbeck,Jochen Müller-Ehmsen,Paul Vermeersch,Danny Schoors,Mark Rosenberg,Florian Bea,Shmuel Tuvia,Jonathan Leor +9 more
TL;DR: This first-in-man pilot study shows that intracoronary deployment of an IK-5001 scaffold is feasible and well tolerated and promoted the initiation of a multicenter, randomized controlled trial to confirm the safety and efficacy of this new approach in high-risk patients after ST-segment–elevation myocardial infarction.
140
The L-Arginine–Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy
Maike Anderssohn,Mark Rosenberg,Edzard Schwedhelm,Christian Zugck,Matthias Lutz,Nicole Lüneburg,Norbert Frey,Rainer H. Böger +7 more
TL;DR: DCM patients with unfavourable L-arginine-ADMA ratio are at increased risk for death.
49
Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
Mark Rosenberg,Matthias Waliszewski,Matthias Waliszewski,Florian Krackhardt,Kenneth Chin,Wan Azman Wan Ahmad,Giuseppe Caramanno,Diego Milazzo,Amin Ariff Nuruddin,Houng Bang Liew,Oteh Maskon,Angela Bento,Jean Christophe MacIa,Norbert Frey +13 more
TL;DR: The data demonstrate for the first time that DCB-only PCI of de novo lesions in large coronary arteries (>2.75 mm) is safe and as effective.
Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3.
Alexander Assmann,Andreas Beckmann,Christof Schmid,Karl Werdan,Guido Michels,Oliver Miera,Florian Schmidt,Stefan Klotz,Christoph Starck,Kevin Pilarczyk,Ardawan Rastan,Marion Burckhardt,Monika Nothacker,Ralf Müllenbach,York Zausig,Nils Haake,Heinrich Groesdonk,Markus Ferrari,Michael Buerke,Marcus Hennersdorf,Mark Rosenberg,Thomas Schaible,Harald Köditz,Stefan Kluge,Uwe Janssens,Matthias Lubnow,Andreas W. Flemmer,Susanne Herber-Jonat,Lucas Wessel,Dirk Buchwald,Sven Maier,Lars Krüger,Andreas Fründ,Rolf Jaksties,Stefan Fischer,Karsten Wiebe,Christiane S. Hartog,Omer Dzemali,Daniel Zimpfer,Elfriede Ruttmann-Ulmer,Christian Schlensak,Malte Kelm,Stephan M. Ensminger,Udo Boeken +43 more
TL;DR: The first evidence and expert consensus-based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria as discussed by the authors.
28